Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy.
Hattinger CM, Michelacci F, Sella F, Magagnoli G, Benini S, Gambarotti M, Palmerini E, Picci P, Serra M, Ferrari S. Hattinger CM, et al. Among authors: gambarotti m. Histopathology. 2015 Sep;67(3):338-47. doi: 10.1111/his.12653. Epub 2015 Mar 5. Histopathology. 2015. PMID: 25600168
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues.
Della Chiesa M, Falco M, Parolini S, Bellora F, Petretto A, Romeo E, Balsamo M, Gambarotti M, Scordamaglia F, Tabellini G, Facchetti F, Vermi W, Bottino C, Moretta A, Vitale M. Della Chiesa M, et al. Among authors: gambarotti m. Int Immunol. 2010 Feb;22(2):91-100. doi: 10.1093/intimm/dxp116. Epub 2009 Dec 14. Int Immunol. 2010. PMID: 20008459
Metaplastic carcinoma of the breast with dominant squamous and sebaceous differentiation in the primary tumor and osteochondroid metaplasia in a distant metastasis: report of a case with review of sebaceous differentiation in breast tumors.
Carlucci M, Iacobellis M, Colonna F, Marseglia M, Gambarotti M, Giardina C, Bisceglia M. Carlucci M, et al. Among authors: gambarotti m. Int J Surg Pathol. 2012 Jun;20(3):284-96. doi: 10.1177/1066896911417711. Epub 2011 Aug 24. Int J Surg Pathol. 2012. PMID: 21865268 Review.
Chondrosarcomas revisited.
Mavrogenis AF, Gambarotti M, Angelini A, Palmerini E, Staals EL, Ruggieri P, Papagelopoulos PJ. Mavrogenis AF, et al. Among authors: gambarotti m. Orthopedics. 2012 Mar 7;35(3):e379-90. doi: 10.3928/01477447-20120222-30. Orthopedics. 2012. PMID: 22385450
Outcome of advanced, unresectable conventional central chondrosarcoma.
van Maldegem AM, Gelderblom H, Palmerini E, Dijkstra SD, Gambarotti M, Ruggieri P, Nout RA, van de Sande MA, Ferrari C, Ferrari S, Bovée JV, Picci P. van Maldegem AM, et al. Among authors: gambarotti m. Cancer. 2014 Oct 15;120(20):3159-64. doi: 10.1002/cncr.28845. Epub 2014 Jul 3. Cancer. 2014. PMID: 24995550 Free article.
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.
Grignani G, Palmerini E, Ferraresi V, D'Ambrosio L, Bertulli R, Asaftei SD, Tamburini A, Pignochino Y, Sangiolo D, Marchesi E, Capozzi F, Biagini R, Gambarotti M, Fagioli F, Casali PG, Picci P, Ferrari S, Aglietta M; Italian Sarcoma Group. Grignani G, et al. Among authors: gambarotti m. Lancet Oncol. 2015 Jan;16(1):98-107. doi: 10.1016/S1470-2045(14)71136-2. Epub 2014 Dec 11. Lancet Oncol. 2015. PMID: 25498219 Free article. Clinical Trial.
150 results